HLTRF (HLS Therapeutics) Change In Inventory : $1.02 Mil (TTM As of Sep. 2024)

View and export this data going back to 2010. Start your Free Trial

What is HLS Therapeutics Change In Inventory?

HLS Therapeutics's change in inventory for the quarter that ended in Sep. 2024 was $1.22 Mil. It means HLS Therapeutics's inventory declined by $1.22 Mil from Jun. 2024 to Sep. 2024 .

HLS Therapeutics's change in inventory for the fiscal year that ended in Dec. 2023 was $-0.66 Mil. It means HLS Therapeutics's inventory increased by $0.66 Mil from Dec. 2022 to Dec. 2023 .

HLS Therapeutics's Total Inventories for the quarter that ended in Sep. 2024 was $7.68 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. HLS Therapeutics's Days Inventory for the quarter that ended in Sep. 2024 was 336.40.

Inventory Turnover measures how fast the company turns over its inventory within a year. HLS Therapeutics's Inventory Turnover for the quarter that ended in Sep. 2024 was 0.27.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. HLS Therapeutics's Inventory-to-Revenue for the quarter that ended in Sep. 2024 was 0.58.

HLS Therapeutics Change In Inventory Historical Data

The historical data trend for HLS Therapeutics's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLS Therapeutics Change In Inventory Chart

HLS Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

-0.50

-8.08

1.77

-0.62

-0.66

HLS Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Inventory	Get a 7-Day Free Trial															1.02	-0.61	-0.77	1.19	1.22

HLS Therapeutics Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.02 Mil.

HLS Therapeutics (OTCPK:HLTRF) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

HLS Therapeutics's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	8.2395	/	2.235	*	365 / 4
	=	336.40

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

HLS Therapeutics's Inventory Turnover for the quarter that ended in Sep. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	2.235	/	8.2395
	=	0.27

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

HLS Therapeutics's Inventory to Revenue for the quarter that ended in Sep. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	8.2395	/	14.085
	=	0.58

HLS Therapeutics Change In Inventory Related Terms

Thank you for viewing the detailed overview of HLS Therapeutics's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

HLS Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HLS Therapeutics Inc (OTCPK:HLTRF) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

HLS:Canada

Address

10 Carlson Court, Suite 701, Etobicoke, ON, CAN, M9W 6L2

Website

https://www.hlstherapeutics.com

HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company products include Clozaril, Vascepa, CSAN Pronto, and others. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, and the United States, and the Rest of the world.